About the LFB Group

LFB is a biopharmaceutical group that develops, manufactures and markets plasma-derived medicinal products and recombinant proteins for the treatment of patients with serious and often rare diseases.

Created in France in 1994, LFB is today one of the leading European companies providing plasma-derived and recombinant medicinal products to healthcare professionals.

Its mission is to offer patients new treatment options for unmet needs in three major therapeutic areas: immunology, haemostasis and intensive care.

Every year, LFB’s 15 biopharmaceuticals are used to treat hundreds of thousands of patients with serious and often rare diseases in more than 30 countries.

 

 

See also

THE LFB 2021 COPORATE BROCHURE IN VIDEO